Oncology & Cancer
New target for cancer therapy identified, preclinical study shows
Scientists from the Ludwig Institute for Cancer Research (LICR) in Brussels identified a new target for cancer therapy, an enzyme which prevents the immune system from recognizing and destroying certain types of tumors. Called ...
Jan 31, 2012
0
0